GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Research & Development

Gubra AS (CHIX:GUBRAC) Research & Development : kr89.2 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Gubra AS's Research & Development for the six months ended in Dec. 2023 was kr47.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was kr89.2 Mil.

Gubra AS Research & Development Historical Data

The historical data trend for Gubra AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Research & Development Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- 34.19 27.06 56.84 89.23

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial - 21.64 35.20 41.95 47.27

Gubra AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr89.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS  (CHIX:GUBRAc) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Gubra AS Research & Development Related Terms

Thank you for viewing the detailed overview of Gubra AS's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Gubra AS (CHIX:GUBRAC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Research & Development
Comparable Companies
OCSE:PEG A OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN XKRX:068270 XBRU:UCB RPRX INCY
Traded in Other Exchanges
GUBRA:Denmark PI3:Germany
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Website
https://www.gubra.dk
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (CHIX:GUBRAC) Headlines

No Headlines